Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties
- PMID: 1288944
Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties
Similar articles
-
Lisinopril for hypertension.Med Lett Drugs Ther. 1988 Apr 8;30(763):41-2. Med Lett Drugs Ther. 1988. PMID: 2832713 Clinical Trial. No abstract available.
-
Lisinopril--another ACE inhibitor.Drug Ther Bull. 1989 Apr 17;27(8):31-2. Drug Ther Bull. 1989. PMID: 2562398 Review. No abstract available.
-
[Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].MMW Fortschr Med. 2003 Oct 2;145(40):46. MMW Fortschr Med. 2003. PMID: 14603605 German. No abstract available.
-
[A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure].Vnitr Lek. 1997 Jun;43(6):351-8. Vnitr Lek. 1997. PMID: 9601863 Clinical Trial. Czech.
-
[A new angiotensin-converting enzyme inhibitor is imminent].Fortschr Med. 1988 Jul 30;106(22):463-6. Fortschr Med. 1988. PMID: 2851512 Review. German. No abstract available.
Cited by
-
Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.Eur J Clin Pharmacol. 1995;49(1-2):95-102. doi: 10.1007/BF00192366. Eur J Clin Pharmacol. 1995. PMID: 8751029 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical